AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glitaray M Plus 3mg/850mg Tablet

Prescription Icon
Prescription Required

Marketer

Lloyd Healthcare Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (850mg)

Overview Glitaray M Plus 3mg/850mg Tablet

Diabex Duo 3mg/850mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before initiating treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended by your physician.

Primary Ingredients of Glitaray M Plus 3mg/850mg Tablet

No information provided. A rephrased version cannot be created.

Uses of Glitaray M Plus 3mg/850mg Tablet

Managing type 2 diabetes

Major Benefits of Glitaray M Plus 3mg/850mg Tablet:

Consume Glitaray M Plus 3mg/850mg tablets as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Glitaray M Plus 3mg/850mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glitaray M Plus 3mg/850mg Tablet:

Consume Glitaray M Plus 3mg/850mg tablets precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablets whole; avoid chewing, crushing, or fracturing them. Administer this medication with a meal.

How Glitaray M Plus 3mg/850mg Tablet works:

Each Glitaray M Plus 3mg/850mg tablet combines glimepiride (a sulfonylurea) and metformin (a biguanide) to manage blood sugar. Glimepiride stimulates pancreatic insulin release, reducing blood glucose. Metformin acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glitaray M Plus 3mg/850mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glitaray M Plus 3mg/850mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Concurrent use of Glitaray M Plus 3mg/850mg tablets and breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glitaray M Plus 3mg/850mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of this medication. Renal function should be regularly monitored during treatment. Physician consultation is recommended.

LiverLiverCAUTION

Patients with liver impairment should use Glitaray M Plus 3mg/850mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Initiation of Glitaray M Plus 3mg/850mg tablets usually begins with a reduced dose for those with mild to moderate hepatic dysfunction; however, it's contraindicated in patients with severe liver disease.

What if you forget to take Glitaray M Plus 3mg/850mg Tablet :

Should you forget to take your Glitaray M Plus 3mg/850mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glitaray M Plus 3mg/850mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glitaray M Plus 3mg/850mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Glitaray M Plus 3mg/850mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue use and seek immediate medical attention.
Glitaray M Plus 3mg/850mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glitaray M Plus 3mg/850mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glitaray M Plus 3mg/850mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems—ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glitaray M Plus 3mg/850mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glitaray M Plus 3mg/850mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glitaray M Plus 3mg/850mg...
95
MRP 110
13% off